摘要:
Morphing structural features of HTS-derived chemotypes led to the discovery of novel 2-cyano-pyrimidine inhibitors of cathepsin K with good pharmacokinetic profiles, for example, compound 20 showed high catK potency (IC(50) = 4 nM), >580-fold selectivity over catL and catB, and oral bioavailability in the rat of 52%. (C) 2010 Elsevier Ltd. All rights reserved.